Literature DB >> 25824471

Quadrivalent human papillomavirus vaccination: a promising treatment for recalcitrant cutaneous warts in children.

Dietrich Abeck1, Regina Fölster-Holst.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25824471     DOI: 10.2340/00015555-2111

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  6 in total

1.  Nonavalent Human Papillomavirus Vaccination as a Treatment for Skin Warts in Immunosuppressed Adults: A Case Series.

Authors:  Simon Bossart; Valentina Imstepf; Robert E Hunger; S Morteza Seyed Jafari
Journal:  Acta Derm Venereol       Date:  2020-03-12       Impact factor: 3.875

2.  Nonavalent human papillomavirus vaccination as a treatment for warts in an immunosuppressed adult.

Authors:  Sara B Ferguson; Elisa S Gallo
Journal:  JAAD Case Rep       Date:  2017-07-26

Review 3.  New Developments in Bacterial, Viral, and Fungal Cutaneous Infections.

Authors:  Samuel Yeroushalmi; Joshua Yoseph Shirazi; Adam Friedman
Journal:  Curr Dermatol Rep       Date:  2020-03-05

4.  The Relationship between the Soluble Receptor for Advanced Glycation End Products and Oxidative Stress in Patients with Palmoplantar Warts.

Authors:  Cristina Iulia Mitran; Ilinca Nicolae; Mircea Tampa; Madalina Irina Mitran; Constantin Caruntu; Maria Isabela Sarbu; Corina Daniela Ene; Clara Matei; Antoniu Cringu Ionescu; Simona Roxana Georgescu; Mircea Ioan Popa
Journal:  Medicina (Kaunas)       Date:  2019-10-20       Impact factor: 2.430

5.  Posttranslational Modifications Pattern in Clear Cell Renal Cell Carcinoma.

Authors:  Corina Daniela Ene; Mircea Nicolae Penescu; Simona Roxana Georgescu; Mircea Tampa; Ilinca Nicolae
Journal:  Metabolites       Date:  2020-12-27

6.  HPV Vaccination Status and Resolution of Warts in Pediatric Patients.

Authors:  Anuk Burli; Sarah Hancock; Yu Tina Zhao; Deborah Paul; Maria Cordisco
Journal:  Indian J Dermatol       Date:  2021 Nov-Dec       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.